1. Home
  2. LXP vs RDY Comparison

LXP vs RDY Comparison

Compare LXP & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXP
  • RDY
  • Stock Information
  • Founded
  • LXP 1993
  • RDY 1984
  • Country
  • LXP United States
  • RDY India
  • Employees
  • LXP N/A
  • RDY N/A
  • Industry
  • LXP Real Estate Investment Trusts
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • LXP Real Estate
  • RDY Health Care
  • Exchange
  • LXP Nasdaq
  • RDY Nasdaq
  • Market Cap
  • LXP 2.6B
  • RDY 2.1B
  • IPO Year
  • LXP 1993
  • RDY N/A
  • Fundamental
  • Price
  • LXP $8.74
  • RDY $15.23
  • Analyst Decision
  • LXP Hold
  • RDY Strong Buy
  • Analyst Count
  • LXP 3
  • RDY 2
  • Target Price
  • LXP $10.50
  • RDY $16.95
  • AVG Volume (30 Days)
  • LXP 2.9M
  • RDY 1.7M
  • Earning Date
  • LXP 07-30-2025
  • RDY 07-28-2025
  • Dividend Yield
  • LXP 6.17%
  • RDY 0.63%
  • EPS Growth
  • LXP 402.06
  • RDY 1.47
  • EPS
  • LXP 0.20
  • RDY 0.79
  • Revenue
  • LXP $361,070,000.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • LXP N/A
  • RDY $10.24
  • Revenue Next Year
  • LXP $7.28
  • RDY N/A
  • P/E Ratio
  • LXP $44.66
  • RDY $19.24
  • Revenue Growth
  • LXP 5.67
  • RDY 16.61
  • 52 Week Low
  • LXP $6.85
  • RDY $12.26
  • 52 Week High
  • LXP $10.57
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • LXP 63.15
  • RDY 55.04
  • Support Level
  • LXP $8.46
  • RDY $15.16
  • Resistance Level
  • LXP $8.71
  • RDY $16.17
  • Average True Range (ATR)
  • LXP 0.15
  • RDY 0.20
  • MACD
  • LXP -0.01
  • RDY -0.07
  • Stochastic Oscillator
  • LXP 77.78
  • RDY 39.74

About LXP LXP Industrial Trust (Maryland REIT)

LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: